行情

PSTX

PSTX

POSEIDA THERAPEUTICS, INC.
NASDAQ

实时行情|Nasdaq Last Sale

0.0000
0.00%
已收盘, 09:30 09/19 EDT
开盘
--
昨收
--
最高
--
最低
--
成交量
--
成交额
--
52周最高
--
52周最低
--
市值
--
市盈率(TTM)
--
分时
5日
1月
3月
1年
5年

PSTX 新闻

  • 外盘头条:特朗普称鲍威尔的工作很安全但降息不够多
  • 新浪美股.2小时前
  • 经济学家称通用汽车罢工或将密歇根州推入经济衰退
  • 新浪美股.2小时前
  • 微软收涨近2% 盘中股价创历史新高
  • 新浪美股.2小时前
  • 上诉机构法官任期将满 世贸组织或遭受致命一击
  • 新浪美股.3小时前

更多

所属板块

生物技术和医学研究
+0.06%
制药与医学研究
+0.42%

热门股票

名称
价格
涨跌幅

PSTX 简况

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops gene engineering technologies to create therapeutics for patients with unmet medical need. The Company has built a pipeline of autologous and allogeneic chimeric antigen receptor thymus (T) cell product candidates, which is focused on the treatment of hematological malignancies and solid tumors. Its P- bone marrow cell maturation antigen (BCMA)-101 is an autologous chimeric antigen receptor (CAR)-T therapy being developed to treat patients with relapsed or refractory multiple myeloma. P-PSMA-101 is an autologous CAR-T product candidate that enables treatment of patients with castrate-resistant prostate cancer (CRPC). P-BCMA-ALLO1 is an allogeneic CAR-T product candidate using cells derived from a donor as starting material that enables treatment of patients with multiple myeloma from a single manufacturing run.
展开

Webull提供Poseida Therapeutics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。